Drug interactions for the following drug(s)
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluticasone.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet
Acetylsalicylic acid may decrease the excretion rate of Triamterene which could result in a higher serum level.
Applies to: triamcinolone acetonide 0.05 % Topical Ointment <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Triamcinolone.
Applies to: Furosemide 20 MG Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The therapeutic efficacy of Furosemide can be increased when used in combination with Fluticasone propionate.
Applies to: Furosemide 20 MG Oral Tablet <> triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet
The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Furosemide.
Applies to: Furosemide 20 MG Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
Furosemide may increase the excretion rate of Potassium chloride which could result in a lower serum level and potentially a reduction in efficacy.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
The risk or severity of hyperkalemia can be increased when Potassium chloride is combined with Triamterene.
Applies to: Tums 1177 MG Chewable Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The bioavailability of Fluticasone can be decreased when combined with Calcium carbonate.
Applies to: Furosemide 20 MG Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
The protein binding of Furosemide can be decreased when combined with Levothyroxine.
Applies to: triamcinolone acetonide 0.05 % Topical Ointment <> Tums 1177 MG Chewable Tablet
The bioavailability of Triamcinolone can be decreased when combined with Calcium carbonate.
Applies to: levothyroxine sodium 150 MCG Oral Tablet <> Tums 1177 MG Chewable Tablet
Calcium carbonate can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> Tums 1177 MG Chewable Tablet
Hydrochlorothiazide may decrease the excretion rate of Calcium carbonate which could result in a higher serum level.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Hydrochlorothiazide may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: triamcinolone acetonide 0.05 % Topical Ointment <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Triamcinolone.
Applies to: Lisinopril 5 MG Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
The risk or severity of hyperkalemia can be increased when Potassium chloride is combined with Lisinopril.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
Acetylsalicylic acid may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Acetylsalicylic acid.
Applies to: Furosemide 20 MG Oral Tablet <> Lisinopril 5 MG Oral Tablet
The risk or severity of renal failure and hypotension can be increased when Furosemide is combined with Lisinopril.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The risk or severity of gastrointestinal irritation can be increased when Fluticasone propionate is combined with Acetylsalicylic acid.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> Furosemide 20 MG Oral Tablet
The risk or severity of increased serum creatinine can be increased when Acetylsalicylic acid is combined with Furosemide.
Applies to: levothyroxine sodium 150 MCG Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The metabolism of Levothyroxine can be decreased when combined with Fluticasone furoate.
Applies to: fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Acetylsalicylic acid may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: Lisinopril 5 MG Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Folic acid may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
The risk or severity of electrolyte imbalance can be increased when Triamcinolone is combined with Hydrochlorothiazide.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Hydrochlorothiazide.
Applies to: Furosemide 20 MG Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Furosemide.
Applies to: Furosemide 20 MG Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Furosemide may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: levothyroxine sodium 150 MCG Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
The metabolism of Levothyroxine can be increased when combined with Triamcinolone.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> Lisinopril 5 MG Oral Tablet
The therapeutic efficacy of Lisinopril can be decreased when used in combination with Acetylsalicylic acid.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> Lisinopril 5 MG Oral Tablet
The risk or severity of hyperkalemia can be increased when Triamterene is combined with Lisinopril.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
The therapeutic efficacy of Levothyroxine can be increased when used in combination with Acetylsalicylic acid.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to cholecalciferol, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Cholecalciferol and Fluticasone. Drug1 is resolved to cholecalciferol, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Cholecalciferol and Fluticasone furoate. Drug1 is resolved to cholecalciferol, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Cholecalciferol and Fluticasone propionate.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Acetylsalicylic acid and Triamterene. Drug1 is resolved to aspirin, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Acetylsalicylic acid and Hydrochlorothiazide.
Applies to: triamcinolone acetonide 0.05 % Topical Ointment <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Drug1 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to cholecalciferol, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Cholecalciferol and Triamcinolone.
Applies to: Furosemide 20 MG Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Furosemide and Fluticasone propionate. Drug1 is resolved to furosemide, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Furosemide and Fluticasone.
Applies to: Furosemide 20 MG Oral Tablet <> triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet
Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Furosemide and Triamterene. Drug1 is resolved to furosemide, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Furosemide and Hydrochlorothiazide.
Applies to: Furosemide 20 MG Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Furosemide and Potassium chloride.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Potassium chloride and Triamterene. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Hydrochlorothiazide and Potassium chloride.
Applies to: Tums 1177 MG Chewable Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Calcium carbonate and Fluticasone. Drug1 is resolved to calcium carbonate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Calcium carbonate and Fluticasone propionate.
Applies to: Furosemide 20 MG Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Furosemide and Levothyroxine.
Applies to: triamcinolone acetonide 0.05 % Topical Ointment <> Tums 1177 MG Chewable Tablet
Drug1 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug2 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Calcium carbonate and Triamcinolone.
Applies to: levothyroxine sodium 150 MCG Oral Tablet <> Tums 1177 MG Chewable Tablet
Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Calcium carbonate and Levothyroxine.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> Tums 1177 MG Chewable Tablet
Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1653049, name = calcium carbonate 1177 MG Chewable Tablet [Tums], tty = SBD). Drug1 is resolved to calcium carbonate, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Calcium carbonate and Hydrochlorothiazide.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Folic acid and Hydrochlorothiazide. Drug1 is resolved to cholecalciferol, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Cholecalciferol and Hydrochlorothiazide. Drug1 is resolved to folic acid, Drug2 is resolved to triamterene and interaction asserted in DrugBank between Folic acid and Triamterene.
Applies to: triamcinolone acetonide 0.05 % Topical Ointment <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to triamcinolone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Triamcinolone and Fluticasone propionate. Drug1 is resolved to triamcinolone, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Triamcinolone and Fluticasone. Drug1 is resolved to triamcinolone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Triamcinolone and Fluticasone furoate.
Applies to: Lisinopril 5 MG Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
Drug1 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Potassium chloride and Lisinopril. Drug1 is resolved to potassium chloride, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Potassium chloride and Lisinopril.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> potassium chloride 10 MEQ Microencapsulated Extended Release Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1801298, name = Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Acetylsalicylic acid and Potassium chloride.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Acetylsalicylic acid and Triamcinolone.
Applies to: Furosemide 20 MG Oral Tablet <> Lisinopril 5 MG Oral Tablet
Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Furosemide and Lisinopril. Drug1 is resolved to furosemide, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Furosemide and Lisinopril.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone propionate. Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone. Drug1 is resolved to aspirin, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Acetylsalicylic acid and Fluticasone furoate.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> Furosemide 20 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to furosemide and interaction asserted in DrugBank between Acetylsalicylic acid and Furosemide.
Applies to: levothyroxine sodium 150 MCG Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Levothyroxine and Fluticasone furoate. Drug1 is resolved to levothyroxine, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Levothyroxine and Fluticasone propionate. Drug1 is resolved to levothyroxine, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Levothyroxine and Fluticasone.
Applies to: fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone propionate. Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to folic acid and interaction asserted in DrugBank between Acetylsalicylic acid and Folic acid.
Applies to: Lisinopril 5 MG Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Drug1 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Folic acid and Lisinopril. Drug1 is resolved to folic acid, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Folic acid and Lisinopril.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Hydrochlorothiazide and Triamcinolone.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1797907, name = fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, tty = SCD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Hydrochlorothiazide and Fluticasone furoate. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Hydrochlorothiazide and Fluticasone propionate. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Hydrochlorothiazide and Fluticasone.
Applies to: Furosemide 20 MG Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Furosemide and Triamcinolone.
Applies to: Furosemide 20 MG Oral Tablet <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Drug1 (rxcui = 310429, name = furosemide 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to furosemide and interaction asserted in DrugBank between Folic acid and Furosemide.
Applies to: levothyroxine sodium 150 MCG Oral Tablet <> triamcinolone acetonide 0.05 % Topical Ointment
Drug1 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1090641, name = triamcinolone acetonide 0.0005 MG/MG Topical Ointment, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to triamcinolone and interaction asserted in DrugBank between Levothyroxine and Triamcinolone.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> Lisinopril 5 MG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Acetylsalicylic acid and Lisinopril. Drug1 is resolved to aspirin, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Acetylsalicylic acid and Lisinopril.
Applies to: triamterene 37.5 MG / hydrochlorothiazide 25 MG Oral Tablet <> Lisinopril 5 MG Oral Tablet
Drug1 (rxcui = 310812, name = hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 311354, name = lisinopril 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to triamterene, Drug2 is resolved to lisinopril anhydrous and interaction asserted in DrugBank between Triamterene and Lisinopril. Drug1 is resolved to triamterene, Drug2 is resolved to lisinopril and interaction asserted in DrugBank between Triamterene and Lisinopril.
Applies to: Aspirin 81 MG Delayed Release Oral Tablet <> levothyroxine sodium 150 MCG Oral Tablet
Drug1 (rxcui = 308416, name = aspirin 81 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 966225, name = levothyroxine sodium 0.15 MG Oral Tablet, tty = SCD). Drug1 is resolved to aspirin, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Acetylsalicylic acid and Levothyroxine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.